8-K 1 f97350e8vk.htm 8-K e8vk
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

March 15, 2004

(Date of earliest event reported)

GENELABS TECHNOLOGIES, INC.

(Exact name of Registrant as specified in its charter)
         
California   0-19222   94-3010150
  		 
  		 
 
(State of Incorporation)   (Commission File No.)   (IRS Employer
Identification No.)

505 Penobscot Drive, Redwood City, California 94063

(Address of principal executive offices, including zip code)

(650) 369-9500

(Registrant’s telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

TABLE OF CONTENTS

ITEM 7. EXHIBITS
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
SIGNATURE
EXHIBIT INDEX
EXHIBIT 99.1

Table of Contents

ITEM 7. EXHIBITS

99.1   Press Release of Registrant, dated March 15, 2004, entitled “Genelabs Technologies Reports 2003 Year-End and Fourth Quarter Financial Results.”

ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION

     On March 15, 2004, Genelabs Technologies, Inc., a California corporation (“Registrant”), announced its 2003 year-end and fourth quarter financial results. The text of the press release is furnished as Exhibit 99.1 to this Form 8-K.

2

Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
         
  GENELABS TECHNOLOGIES, INC.
 		  
  By:   /s/ Matthew M. Loar    
    Name:   Matthew M. Loar   
    Title:   Chief Financial Officer   
 

Date: March 15, 2004

3

Table of Contents

EXHIBIT INDEX

     
EXHIBIT NO.
   DESCRIPTION
99.1
  Press Release of Registrant, dated March 15, 2004, entitled “Genelabs Technologies Reports 2003 Year-End and Fourth Quarter Financial Results.”